Mini-reviewMetabolic therapy: A new paradigm for managing malignant brain cancer
Section snippets
Glioblastoma multiforme (GBM)
GBM is the most malignant of the primary brain cancers with only about 12% of patients surviving beyond 36 months (long-term survivors) [1], [2], [3]. Most glioblastomas are heterogeneous in cellular composition consisting of tumor stem cells, mesenchymal cells, and host stromal cells [4], [5], [6], [7], [8], [9]. Primary GBM can arise de novo, whereas secondary GBM is thought to arise from lower-grade gliomas [6], [10], [11]. The timing and incidence of malignant progression from low-grade
Standard of care for malignant glioma
The current standard of care for GBM and many malignant brain cancers includes maximum surgical resection, radiation therapy, and chemotherapy [2], [55], [56], [57]. The toxic alkylating agent, temozolomide (TMZ), is the most common chemotherapy used for treating GBM. The most common adverse events of TMZ exposure besides hematological toxicities are alopecia, nausea, vomiting, anorexia, headache, and constipation. These adverse effects have been described on the NCI web site (//www.cancer.gov
Mitochondrial abnormalities in malignant brain tumors
Substantial evidence collected from numerous investigators over many years indicates that abnormalities in mitochondrial structure and function are the hallmark of most cancers including brain cancer [69], [70], [71], [72], [73], [74]. These mitochondrial abnormalities will reduce energy production through oxidative phosphorylation (OxPhos) [69], [70], [71], [72], [75], [76], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86]. Although pathological mitochondrial DNA (mtDNA) mutations
The Warburg effect in malignant brain tumors
Otto Warburg first proposed that all cancers arise from irreversible damage to cellular respiration. As a result, cancer cells increase their capacity to ferment lactate even in the presence of oxygen in order to compensate for their insufficient respiration [108], [109]. Although confusion has surrounded Warburg’s hypothesis on the origin of cancer cells [39], [110], [111], his hypothesis has never been formally disproved and remains a credible explanation for the origin of tumor cells [39],
Role of glucose and glutamine in brain tumor progression
Glucose is the predominant fuel of the brain, but also fuels tumor cell glycolysis as well as serving as a precursor for glutamate synthesis [107], [109], [153], [154]. Using linear regression analysis, we showed that the growth rate of the CT-2A experimental mouse astrocytoma was directly dependent on blood glucose levels [153]. The higher the blood glucose levels, the faster the tumors grew. As glucose levels fall, tumor size and growth rate falls. Hyperglycemia not only contributes to rapid
Does the current standard of care accelerate GBM recurrence and progression through effects on energy metabolism?
It is our view that the current standard of care for managing GBM and other malignant brain cancers will contribute to tumor recurrence and progression. This prediction comes from information describing how the standard of care can enhance the availability of glucose and glutamine within the tumor microenvironment [16], [130], [176]. It is well documented that neurotoxicity from mechanical trauma (surgery), radiotherapy, and chemotherapy, can increase tissue inflammation and glutamate levels
The calorie restricted ketogenic diet as a non-toxic metabolic therapy for brain cancer
Emerging evidence suggests that metabolic therapies using ketogenic diets that lower glucose levels can help retard GBM growth in younger and older patients [227], [228], [229]. Restricted diets are those that deliver fewer total calories in order to lower circulating glucose and insulin levels. We found that the KD reduced brain cancer growth and angiogenesis in mice only when administered in restricted amounts [65], [153], [210]. The importance of this point cannot be overemphasized, as
Conflict of interest
None of the authors have a conflict of interest.
Acknowledgements
This work was supported in part from NIH - United States Grants (HD-39722, NS-1080 55195, and CA-102135), a Grant from the American Institute of Cancer Research, and the Boston College Expense Fund. We thank Dr. Giulio Zuccoli and Jeremy Marsh for helpful comments, which were included in our similar review published in “Oncology & Hematology Reviews” and cited as reference 176 in the current review.
References (258)
- et al.
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC–NCIC trial
Lancet Oncol.
(2009) - et al.
A hierarchy of self-renewing tumor-initiating cell types in glioblastoma
Cancer Cell
(2010) - et al.
Does the existing standard of care increase glioblastoma energy metabolism?
Lancet Oncol.
(2010) - et al.
Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies
Am. J. Pathol.
(2005) - et al.
The pathways of extraneural spread in metastasizing gliomas: a report of three cases and critical review of the literature
Hum. Pathol.
(1979) - et al.
Hypoxia- and vascular endothelial growth factor-induced stromal cell-derived factor-1alpha/CXCR4 expression in glioblastomas: one plausible explanation of Scherer’s structures
Am. J. Pathol.
(2008) - et al.
The somatic genomic landscape of glioblastoma
Cell
(2013) - et al.
Mitochondrial retrograde signaling at the crossroads of tumor bioenergetics, genetics and epigenetics
Mitochondrion
(2013) The retrograde response links metabolism with stress responses, chromatin-dependent gene activation, and genome stability in yeast aging
Gene
(2005)Retrograde regulation due to mitochondrial dysfunction may be an important mechanism for carcinogenesis
Med. Hypotheses
(2005)
Inter-genomic cross talk between mitochondria and the nucleus plays an important role in tumorigenesis
Gene
Is the restricted ketogenic diet a viable alternative to the standard of care for managing malignant brain cancer?
Epilepsy Res.
Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of radiation therapy oncology group 93-05 protocol
Int. J. Radiat. Oncol. Biol. Phys.
Mitochondrial dysfunction in gliomas
Semin. Pediatr. Neurol.
Dysfunctional mitochondria, not oxygen insufficiency, cause cancer cells to produce inordinate amounts of lactic acid: the impact of this on the treatment of cancer
Med. Hypotheses
Electron microscopy morphology of the mitochondrial network in human cancer
Int. J. Biochem. Cell Biol.
The proton stoichiometry of electron transport in Ehrlich ascites tumor mitochondria
J. Biol. Chem.
Warburg tumours and the mechanisms of mitochondrial tumour suppressor genes. Barking up the right tree?
Curr. Opin. Genet. Dev.
Mitochondrial gateways to cancer
Mol. Aspects Med.
Cardiolipin and electron transport chain abnormalities in mouse brain tumor mitochondria: lipidomic evidence supporting the Warburg theory of cancer
J. Lipid Res.
Cardiolipin requirement for electron transfer in complexs I and III of the mitochondrial respiratory chain
J. Biol. Chem.
The complexity of cardiolipin in health and disease
Trends Biochem. Sci.
Malignant gliomas in 2005: where to GO from here?
JAMA
Long-term survival with glioblastoma multiforme
Brain
Established and emerging variants of glioblastoma multiforme: review of morphological and molecular features
Folia Neuropathol.
Genetic alterations and signaling pathways in the evolution of gliomas
Cancer Sci.
Glioma cell populations grouped by different cell type markers drive brain tumor growth
Cancer Res.
Primary glioblastomas express mesenchymal stem-like properties
Mol. Cancer Res.
Tumors of the central nervous system
The world health organization classification of nervous system tumors in experimental neuro-oncology
Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma
Science
Low-grade gliomas in adults
J. Neurosurg.
Immunohistological evaluation of macrophage infiltrates in brain tumors. Correlation with peritumoral edema
J. Neurosurg.
Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas
Clin. Cancer Res.
Lymphoreticular cells in human brain tumours and in normal brain
Br. J. Cancer
Macrophages in experimental and human brain tumors. Part 2: Studies of the macrophage content of human brain tumors
J. Neurosurg.
Perspectives on brain tumor formation involving macrophages, glia, and neural stem cells
Perspect. Biol. Med.
Fusion of tumour cells with bone marrow-derived cells: a unifying explanation for metastasis
Nat. Rev.
Fusion between Intestinal epithelial cells and macrophages in a cancer context results in nuclear reprogramming
Cancer Res.
Phagocytic properties in tumor astrocytes
Neuropathology
Should EMT of cancer cells be understood as epithelial-myeloid transition?
J. Cancer
Hypothesis: are neoplastic macrophages/microglia present in glioblastoma multiforme?
ASN Neuro
On the origin of cancer metastasis
Crit. Rev. Oncog.
Metastatic glioblastoma: case presentations and a review of the literature
J. Neurooncol.
Extra-neural metastases of malignant gliomas: myth or reality?
Cancers (Basel)
Transmission of glioblastoma multiforme following bilateral lung transplantation from an affected donor: case study and review of the literature
Neuro-oncology
The natural history of extracranial metastasis from glioblastoma multiforme
J. Neuro-oncol.
Surgical treatment of high-grade gliomas in motor areas. The impact of different supportive technologies: a 171-patient series
J. Neuro-oncol.
Untreated glioblastoma multiforme: increased myo-inositol and glutamine levels in the contralateral cerebral hemisphere at proton MR spectroscopy
Radiology
Structural development in gliomas
Am. J. Cancer
Cited by (136)
Exploring the gut microbiota and its potential as a biomarker in gliomas
2024, Biomedicine and PharmacotherapyCytidine deaminase deficiency in mice enhances genetic instability but limits the number of chemically induced colon tumors
2023, Cancer LettersCitation Excerpt :It has been suggested that genetic instability is a by-product of tumorigenesis, with tumors arising due to a disruption of regulatory controls resulting from alterations to the surrounding tissues [23,24]. It has also been suggested that genetic instability is not required for tumor development [25], and that genetic instability in cancer cells is a downstream epiphenomenon resulting from an initial event, the disturbance of cellular energy metabolism [26]. Our results showing that Cda deficiency does not increase the risk of spontaneous cancers, and actually decreases the risk of chemically induced cancers also raises questions about the differences between spontaneous and chemically-induced tumors, potentially reflecting differences in the nature of spontaneous and chemically-induced mutations.
Sp1 promotes tumour progression by remodelling the mitochondrial network in cervical cancer
2023, Journal of Translational MedicineThe Warburg Effect Explained: Integration of Enhanced Glycolysis with Heterogeneous Mitochondria to Promote Cancer Cell Proliferation
2023, International Journal of Molecular Sciences